Policy and Advocacy team

Listing summary

Works with governments, charities, commercial organisations and other funders to influence UK, EU and global policy developments.

English
Standfirst

We aim to influence policy developments so that researchers can be as effective as possible, and health can be improved.

Content
Group
Body

We work with a wide range of partners – including governments, research funders, learned societies, charities and commercial organisations – in the UK, Europe and globally. 

Group title
Team Contacts
Admin title
Team Contacts
Group
Accordion slice
Body

Ed Whiting

Director of Strategy

e.whiting@wellcome.org

Natalie Paloma-Solis

Executive Assistant to Ed Whiting

n.palomasolis@wellcome.org

Title
Policy and Advocacy Directorate
Accordion slice
Body

Beth Thompson

Head of UK and EU Policy and Advocacy

b.thompson@wellcome.org

Michelle Marshall

PA and Team Coordinator

m.marshall@wellcome.org

Catherine Guinard

Policy and Advocacy Manager

c.guinard@wellcome.org

Martin Smith

Policy and Advocacy Manager

Contact about: Brexit.

m.smith@wellcome.org

Natalie Banner

Policy and Advocacy Adviser (on secondment)

Contact about: data protectionpatient data and medical recordsExpert Advisory Group on Data Access, research ethics and governance.

n.banner@wellcome.org

Ben Bleasdale

Senior Policy and Advocacy Adviser

Contact about: UK research investment, funding structures, Research Excellence Framework, What’s it Worth studies.

b.bleasdale@wellcome.org

Amelia Dearman

Policy and Advocacy Adviser

Contact about: immigration, innovation policy, All-Party Parliamentary Group on Medical Research, parliamentary communications, diversity, education and skills.

a.dearman@wellcome.org

Simon Hall

Senior Policy and Advocacy Officer

Contact about: Brexit.

s.hall@wellcome.org

Sarah Rappaport

Policy and Advocacy Adviser

Contact about: emerging science and technologiesmitochondrial donation, regulation of clinical trials, research in the NHS, research involving embryos.

s.rappaport@wellcome.org

Title
UK and EU Policy
Accordion slice
Body

Alex Harris

Head of Global Policy and Advocacy

Contact about: COVID-19

a.harris@wellcome.org

Jack Snow

Team Coordinator

Contact about: general enquiries for Global Policy, cultural engagement.

j.snow@wellcome.org

Anna Lee

Policy and Advocacy Manager

Contact about: research uptakeCOVID-19.

an.lee@wellcome.org

Will Hall

Policy and Advocacy Manager

Contact about: access to healthcare interventions (general), epidemic preparedness, sustainable development goals, COVID-19.

w.hall@wellcome.org

Olivia Allen

Policy and Advocacy Officer

Contact about: access to healthcare interventions (general), research uptakeCOVID-19.

o.allen@wellcome.org

Heather Browett

Senior Policy and Advocacy Officer

Contact about: emerging science and technologiesresearch uptakeCOVID-19.

h.browett@wellcome.org

Alice Jamieson

Policy and Advocacy Adviser

Contact about: epidemic preparedness, sustainable development goals, vaccinesWHO partnershipCOVID-19.

a.jamieson@wellcome.org

Diogo Martins

Policy and Advocacy Officer (on secondment)

Contact about: snakebiteCOVID-19.

d.martins@wellcome.org

Gemma Wardle

Policy and Advocacy Officer

Contact about: access to healthcare interventions, epidemic preparedness, COVID-19.

G.Wardle@wellcome.org

Will O’Leary

Policy and Advocacy Adviser

Contact about: research uptakeCOVID-19.

w.oleary@wellcome.org

Chloe Watson

Policy and Advocacy Adviser

Contact about: access to healthcare interventionsCOVID-19.

c.watson@wellcome.org

Rachael Hore

Policy & Advocacy Officer

Contact about: access to healthcare interventionsCOVID-19

r.hore@wellcome.org

Title
Global Policy
Group title
Our work
Admin title
Our work
Group
Listing layout
Text Listing
Content
Body

We want to help the world overcome Covid-19. Research is the best way to save lives – but more investment in accessible treatments, tests and vaccines is urgently needed to change the course of the pandemic.

Title
Coronavirus (Covid-19): supporting global research and development
Body

At least $8 billion of new funding is needed for the global response to COVID-19 – for research, development and supply of treatments for all, and support for public health measures in countries with the weakest health systems.

Title
Urgent funding gaps in the global response to coronavirus (COVID-19)
Body

Current practices prioritise outputs over people’s wellbeing. We want to help build a better research culture – one that is creative, inclusive and honest.

Title
Research culture: let's reimagine how we work together
Body

How Wellcome is working to ensure that research evidence is used to influence policy and practice.

Title
Supporting the use of research evidence in policy and practice
Body

Research is an essential part of being ready for and responding to public health emergencies, like COVID-19 and Ebola.

Title
Data sharing in public health emergencies
Body

Wellcome is working with the World Health Organization (WHO) to take on big challenges in global health

Title
Wellcome’s partnership with the World Health Organization
Body

Randomised clinical trials are essential to advancing evidence-based medicine and improving human health. But new guidelines are needed, which is why we've launched the Good Clinical Trials Collaborative. 

Title
Good Clinical Trials Collaborative
Body

Everyone should have access to the life-changing benefits of medicines and other healthcare interventions, like vaccines, diagnostics and therapies.

Title
Access to healthcare interventions
Body

We want the research we fund – like publications, data, software and materials – to be open and accessible, so it can have the greatest possible impact.

Title
Open research
Body

Knowledge and understanding don’t stop at borders. We're working with the UK government and others to achieve a Brexit settlement that allows research to thrive in the UK and Europe.

Title
Brexit and the EU
Body

Emerging science and technologies, such as human genome editing and gene drive, could provide new solutions to health problems.

Title
Emerging science and technologies
Body

Patient data is hugely valuable for research. But the value of that data can only be unlocked if concerns about patient privacy are taken seriously.

Title
Patient data in research
Body

We want to secure the investment in research promised by the UK government to overcome the biggest challenges in the world, such as climate change and epidemics.

Title
The R&D decade: making the case for government investment
Body

The European General Data Protection Regulation was agreed in April 2016 and took effect from 25 May 2018.

Title
Data Protection Regulation
Body

The European Commission has published a proposal to update EU copyright law so that it applies equally across Europe and is fit for purpose in the 21st century.

Title
EU copyright law reform
Body

Almost every major breakthrough in human and veterinary medicine has depended on the use of animals to research, develop or test new therapies.

Title
Research involving animals
Body

Mitochondrial donation is an IVF technique that gives families affected by mitochondrial disease the chance of having healthy children.

Title
Mitochondrial donation
Body

The European Union is revising regulations governing the manufacture and sale of medical devices.

Title
EU medical devices regulations
Body

The Expert Advisory Group on Data Access promoted good working practices, consistent governance and transparent decision making for managing and using data from cohort studies.

Title
Expert Advisory Group on Data Access
Body

The recommendations set out in the review mark one of the first steps towards making sure that promising drugs, devices, diagnostics and digital products are adopted quickly across the NHS.

Title
Accelerated Access Review
Group title
Reports
Admin title
Reports
Group
Listing layout
Text Listing
Content
Linked file
Linked file
Group title
Briefings and responses
Admin title
Briefings and responses
Group
Listing layout
Text Listing
Content
Linked file
Linked file
Linked file
Group title
News
Group
Listing layout
Image card with CTA link (Horizontal card)
Content
Title
ACT now, ACT together to end COVID-19
Content type
Opinion
Published date
Author
Will Hall
Image
A young boy selling face masks in the streets of the Kawangware slums, in Kenya, is being tested for coronavirus.
File size
63420 bytes
Image width
600px
Image height
342px
Filename
act-now-act-together-end-covid-19-20072020-1500x844.jpg
Image
A young boy selling face masks in the streets of the Kawangware slums, in Kenya, is being tested for coronavirus.
Download allowed
On
Title
COVID-Zero: how businesses can play a critical role in bringing the coronavirus pandemic to an end
Content type
Opinon
Published date
Author
Mark Henderson
Image
The letter X on top of a coronavirus, next to the word COVID and number zero.
File size
491300 bytes
Image width
1600px
Image height
578px
Filename
COVID-Zero-header.png
Image
The letter X on top of a coronavirus, next to the word COVID and number zero.
Download allowed
On
Title
Urgent investment needed for diagnostics, treatments and vaccines to end the COVID-19 pandemic
Content type
Opinion
Published date
Author
Alex Harris
Image
A medical staff member disinfects medical equipment in a ward
File size
351941 bytes
Image width
600px
Image height
342px
Filename
covid-19-urgent-investment-needed-180320-1200px.png
Image
A medical staff member disinfects medical equipment in a ward
Download allowed
On
Meta title
Policy and Advocacy team | Wellcome
Published on
Meta description
We aim to influence policy developments so that researchers can be as effective as possible and health can be improved.
Exclude from listings
Off